These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31676442)
21. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients. Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936 [TBL] [Abstract][Full Text] [Related]
22. Molecular recognition between pancreatic lipase and natural and synthetic inhibitors. Bello M; Basilio-Antonio L; Fragoso-Vázquez J; Avalos-Soriano A; Correa-Basurto J Int J Biol Macromol; 2017 May; 98():855-868. PubMed ID: 28212930 [TBL] [Abstract][Full Text] [Related]
23. Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting. Cushing EM; Chi X; Sylvers KL; Shetty SK; Potthoff MJ; Davies BSJ Mol Metab; 2017 Aug; 6(8):809-818. PubMed ID: 28752045 [TBL] [Abstract][Full Text] [Related]
24. Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions. Bustos AS; Håkansson A; Linares-Pastén JA; Peñarrieta JM; Nilsson L PLoS One; 2020; 15(4):e0224853. PubMed ID: 32298262 [TBL] [Abstract][Full Text] [Related]
25. The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding. Mysling S; Kristensen KK; Larsson M; Kovrov O; Bensadouen A; Jørgensen TJ; Olivecrona G; Young SG; Ploug M Elife; 2016 Dec; 5():. PubMed ID: 27929370 [TBL] [Abstract][Full Text] [Related]
26. Computational analysis and enzyme assay of inhibitor response to disease single nucleotide polymorphisms (SNPs) in lipoprotein lipase. He D; Huang L; Xu Y; Pan X; Liu L J Bioinform Comput Biol; 2016 Oct; 14(5):1650028. PubMed ID: 27427383 [TBL] [Abstract][Full Text] [Related]
27. Lipoprotein lipase in mouse kidney: effects of nutritional status and high-fat diet. Nyrén R; Makoveichuk E; Malla S; Kersten S; Nilsson SK; Ericsson M; Olivecrona G Am J Physiol Renal Physiol; 2019 Mar; 316(3):F558-F571. PubMed ID: 30698048 [TBL] [Abstract][Full Text] [Related]
28. Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine. Sternby B; Hartmann D; Borgström B; Nilsson A Clin Nutr; 2002 Oct; 21(5):395-402. PubMed ID: 12381337 [TBL] [Abstract][Full Text] [Related]
29. Missense PNLIP mutations impeding pancreatic lipase secretion cause protein misfolding and endoplasmic reticulum stress. Toldi V; Kassay N; Szabó A Pancreatology; 2021 Oct; 21(7):1317-1325. PubMed ID: 34373204 [TBL] [Abstract][Full Text] [Related]
30. Human pancreatic lipase: colipase dependence and interfacial binding of lid domain mutants. Bezzine S; Ferrato F; Ivanova MG; Lopez V; Verger R; Carrière F Biochemistry; 1999 Apr; 38(17):5499-510. PubMed ID: 10220337 [TBL] [Abstract][Full Text] [Related]
31. In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine. Chen KY; Chang SS; Chen CY PLoS One; 2012; 7(9):e43932. PubMed ID: 22970152 [TBL] [Abstract][Full Text] [Related]
32. Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review. Rajan L; Palaniswamy D; Mohankumar SK Pharmacol Res; 2020 May; 155():104681. PubMed ID: 32045666 [TBL] [Abstract][Full Text] [Related]
33. PPARγ as a sensor of lipase activity and a target for the lipase inhibitor orlistat. Martin H; McGhie TK; Bentley-Hewitt K; Christeller J Lipids Health Dis; 2013 Apr; 12():48. PubMed ID: 23566279 [TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway. Liu G; He L Pharmacology; 2019; 103(5-6):303-314. PubMed ID: 30840953 [TBL] [Abstract][Full Text] [Related]
35. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Borgström B Biochim Biophys Acta; 1988 Oct; 962(3):308-16. PubMed ID: 3167082 [TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-Like Protein 4 and Postprandial Skeletal Muscle Lipid Metabolism in Overweight and Obese Prediabetics. van der Kolk BW; Goossens GH; Jocken JW; Kersten S; Blaak EE J Clin Endocrinol Metab; 2016 Jun; 101(6):2332-9. PubMed ID: 27011113 [TBL] [Abstract][Full Text] [Related]
39. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota. Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266 [TBL] [Abstract][Full Text] [Related]
40. Complete Kinetic Characterization of Enzyme Inhibition in a Single Isothermal Titration Calorimetric Experiment. Di Trani JM; Moitessier N; Mittermaier AK Anal Chem; 2018 Jul; 90(14):8430-8435. PubMed ID: 29926719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]